Tuesday Night IBS

This Tuesday Night IBS webinar features Dr. Kyle Staller an adult gastroenterologist, and Dr. Thomas Wallach a pediatric gastroenterologist. They both discuss how to manage IBS-C in adults and children and whether you should discuss new treatments with your own doctor.

Listen to our 2025 webinar with Dr. Mark Pimentel of MAST at Cedars-Sinai. Dr. Pimentel discusses the newest research on SIBO, IBS and present mock case studies. Mark Pimentel, MD, is the executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai and in collaboration with Ruchi Mathur, MD, whose work focuses on links between metabolic disease and gut microbiome, and Ali Rezaie, MD, whose innovative work in GI motility improves the wellbeing of patients, as part of the MAST team they focus on the development of drugs, diagnostic tests and devices related to conditions of the microbiome. - Pimentel Lab

In this special crossover podcast episode, Tuesday Night IBS co-hosts Jeffrey Roberts MSEd BSc and Erica Dermer are joined live by Dr. William Chey, Amanda Lynett MS RDN and Kate Scarlata MPH RDN at FOOD The Main Course in Ann Arbor, MI. This episode discusses the following topics: The evolution of FOOD: The Main Course over the years and why dietitians should attend The role and benefit of incorporating GI dietitians into integrated care models The evolution of GI dietitians at major GI meetings like DDW IBS, your diet and the microbiome Stress, your diet and IBS GLP-1 use and increased GI symptoms Combating GI misinformation online Ostomies for severe constipation? Check out even more episodes at Healio's Gut Talk Podcast website and submit comments and questions to [email protected]. Check out Tuesday Night IBS for more evidence-based webinars and podcasts at TuesdayNightIBS.com.

In this special crossover podcast episode, Tuesday Night IBS host Jeffrey Roberts, MSEd, BSc, and Kate Scarlata, MPH, RDN, are joined live by William Chey, MD, and Amanda Lynett, MS, RDN, at FOOD the Main Course Conference in Ann Arbor, MI. Amanda Lynett MS, RDN, is a registered dietitian with her masters. Amanda is with the Division of Gastroenterology at Michigan Medical in Ann Arbor. Jeffrey Roberts, MSEd, BSc, is a patient advocate and creator of the first website for IBS sufferers. He is the co-founder of Tuesday Night IBS. Kate Scarlata, MPH, RDN, is a US-based dietitian with over 30 years of experience. Kate’s expertise is in gastrointestinal disorders and food intolerance. We’d love to hear from you! Send your comments/questions to [email protected]. Follow uson X @HealioGastro @sameerkberry @umfoodoc. For more Tuesday Night IBS, be sure check out TuesdayNightIBS.com and to follow and subscribe to their podcast. Disclosures: Chey and Roberts report no relevant financial disclosures. Scarlata reports stock options with Epicured LLC and FODY Food Company, financial support from Dr. Schar, Mahana Therapeutics, Nestle Health Science, Olipop, Pendulum, QOL Medical.

On this special episode of Tuesday Night IBS, we talk with the co-principal investigator, Alex Ford, MD, from Leeds University in the UK, about the ATLANTIS trial of Amitriptyline for irritable bowel syndrome (IBS) in primary care, which was funded by the Health Technology Assessment program of the National Institute for Health and Care Research and the TRITON trial using Ondansetron to manage irritable bowel syndrome with diarrhea. Dr. Alex Ford is a Professor and Honorary consultant gastroenterologist at St. James’s University Hospital, Leeds, UK. His main interest is in the epidemiology, diagnosis, and treatment of disorders of gut-brain interaction, such as irritable bowel syndrome and functional dyspepsia. He is an Associate Editor for Alimentary Pharmacology & Therapeutics. He has published over 450 peer-reviewed articles, including original scientific papers in The Lancet, JAMA, BMJ, Gastroenterology, Gut, Archives of Internal Medicine, and The American Journal of Gastroenterology.